USPTO serial 98229242
DATAVANT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 18, 2025
- Examiner
- KHAN, AHSEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DATAVANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vanessa A. Ignacio, Esq.
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded computer software in the field of electronic medical records used for electronic document storage and management, electronic tracking of release of information requests, providing notification to information requestors regarding status of document requests, scanning and transmission of documents electronically, accounting to patients concerning disclosure of their health information, conversion of paper records to electronic format, management of revenue cycles, processing of insurance claims and collections, medical practice office management, performing audits, and audit management; downloadable artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; downloadable computer programs and computer operating systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; downloadable computer programs and computer operating systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software featuring an electronic computer database for linking, viewing, and de-identifying healthcare and healthcare related data used in the field of healthcare, biomedical research, and clinical trial data; downloadable computer software for accessing data and information related to healthcare services, patient medical information and clinical trial data and for controlling and managing data and information related to healthcare services, patient medical information and clinical trial data; downloadable computer software for creating searchable databases of information and data; downloadable computer software for data processing in the field of healthcare, biomedical research, and clinical trial data; downloadable computer software for data processing; downloadable computer software for database integration; downloadable computer software for providing, transmitting, analyzing and generating reports in the field of healthcare, biomedical research, and clinical trial data; downloadable software for analytics in the field of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable software for data linkage, discovery, and de-identification used in the fields of healthcare, biomedical research, and clinical trial data for the provision of medical services, public health services and healthcare services, none of the foregoing directly related to video surveillance or video based security apparatus | ACTIVE | Nov 7, 2023 |
| 035 | Advertising; analysis of business data; business administration; business analysis and statistical analysis of healthcare data, biomedical research and clinical trial data; business audit services in the healthcare field; business consulting services in the field of hospital and medical practice management; business data analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business data analysis services, namely, providing assessment and management of medical data records; business information management services, namely, tracking documents over computer networks for others; business research and information services; compilation of information into computer databases for research and analysis purposes in the fields of public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; data aggregation services, namely, compiling and analyzing medical data for business purposes; data processing services; management of physical documents for others, namely, arranging for pickup, delivery, storage, and transportation of physical documents via ground and air carriers; market research; medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance; professional business analysis, business consultancy and statistical analysis for business purposes in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; providing information in the field of healthcare records coding, healthcare records management, and healthcare billing practices; records management services, namely, providing reproduction in the nature of photocopying services, management, and indexing of documents via an electronic document system for others; systematization and compilation of data in computer databases | ACTIVE | Nov 7, 2023 |
| 038 | Electronic document delivery services via computer network; electronic transmission of secure messages and data; encrypted electronic transmission and delivery of data | ACTIVE | Nov 7, 2023 |
| 041 | Educational services, namely, developing and conducting classes, seminars, conferences, and workshops in the fields of healthcare records compliance, healthcare records coding, healthcare records management, and healthcare billing practices, and distribution of training materials in connection therewith; educational services, namely, providing educational assessment services in the field of healthcare records and healthcare records coding; computer education training services | ACTIVE | Nov 7, 2023 |
| 042 | Application service provider featuring software for medical data database management and analysis; application service provider featuring software for the collection, sharing, and analysis of patient data; biomedical research services; chemical analysis for industrial purposes; cloud computing, namely, providing temporary use of non-downloadable software for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data; design and development of computer software; document data transfer from one computer format to another and conversion of data or documents from physical to electronic media; electronic storage of documents; pharmaceutical and biomedical research services, in the nature of conducting clinical trials for others, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; providing scientific and technological online information in the fields of public health, healthcare, pharmaceuticals, patient data, biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; providing temporary use of non-downloadable computer software for tracking records and documents over computer networks, intranets and the internet; providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding information, data and analytics in the fields of public health, healthcare, pharmaceuticals, biomedical research, patient data, post-authorization research for marketing of medicines and/or commercial post-launching of medicines, epidemiological and pharmacoepidemiological research and clinical trials; providing temporary use of non-downloadable software applications accessible via a web site for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; providing temporary use of online non-downloadable computer encryption software and software for secure data storage, retrieval, and transmission of confidential health information; records management services, namely, providing retrieval of documents via an electronic document system for others; research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions scientific analysis in the field of scientific data relating to biomedical research and clinical trials; scientific and technological services, namely, medical research and scientific research, and chemical analysis in the healthcare and biomedical field; scientific data processing analysis services, namely, computer programming services for data processing; software as a service (SAAS) services featuring software for collecting, centralizing, coordinating, distributing, storing, managing, analyzing, accessing, and retrieving medical, healthcare, insurance, and biological data and record | ACTIVE | Nov 7, 2023 |
| 045 | Providing information in the field of healthcare records regulatory compliance | ACTIVE | Nov 7, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Datavant, Inc.
- Other trademarks owned by Datavant, Inc.
- Other trademarks owned by Datavant, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named DATAVANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 29, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 26, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 26, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 20, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 20, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 20, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 19, 2025 | IUAF | USE AMENDMENT FILED | — |
| May 19, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 19, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 19, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 8, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 21, 2023 | NWAP | NEW APPLICATION ENTERED | — |